Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Burroni

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Methods in Cell Biology|March 30, 2026
A preclinical organotypic model for evaluating immunotherapy-related toxicitiesAlice Machado, Lene Vimeux, David Espié, et al.
European Journal of Cancer (Oxford, England : 1990)|May 21, 2017
Immune-related bone marrow failure following anti-PD1 therapyJean-Marie Michot, Jacques Vargaftig, Charlotte Leduc, et al.
Oncotarget|April 14, 2017
Mechanisms of PD-1/PD-L1 expression and prognostic relevance in non-Hodgkin lymphoma: a summary of immunohistochemical studiesPauline Gravelle, Barbara Burroni, Sarah Péricart, et al.
Open Forum Infectious Diseases|January 17, 2022
<i>Listeria</i>-Associated Lymphadenitis: A Series of 11 Consecutive Cases and Review of the LiteratureMathieu Blot, Olivier Disson, Alexandre Leclercq, et al.
Haematologica|December 22, 2018
T-cell large granular lymphocyte leukemia transfomation into aggressive T-cell lymphoma: a report of two cases with molecular characterizationMaya Belhadj, Dalila Mansour, Sophie Kaltenbach, et al.
Blood Cells, Molecules & Diseases|December 4, 2019
Mastocytosis onset in a patient with treated hairy cell leukemia: Just a coincidence?Alice Boilève, Adrien Contejean, Sylvain Barreau, et al.
Rheumatology (Oxford, England)|December 23, 2021
Features of non-Hodgkin's lymphoma diagnosed in minor salivary gland biopsies from primary Sjögren's syndrome patientsSimon Parreau, Gaétane Nocturne, Xavier Mariette, et al.
Anti-Cancer Drugs|June 19, 2021
Successful nelarabine and venetoclax treatment of a relapsed/refractory mediastinal myeloid sarcoma with clonal TCR rearrangementAdrien Contejean, Patricia Palmic, Olivier Kosmider, et al.
European Journal of Cancer (Oxford, England : 1990)|October 16, 2024
The tumor immune microenvironment of SCLC is not associated with its molecular subtypesYoan Velut, Basilia Arqué, Marie Wislez, et al.
European Journal of Haematology|November 2, 2023
Extreme thrombocytosis with an aggressive evolution harboring a novel variant of calreticulin (CALR) in exon 3Sarah Bonnet, Serge Carillo, Baptiste Legrand, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Methods in Cell Biology|March 30, 2026
A preclinical organotypic model for evaluating immunotherapy-related toxicitiesAlice Machado, Lene Vimeux, David Espié, et al.
European Journal of Cancer (Oxford, England : 1990)|May 21, 2017
Immune-related bone marrow failure following anti-PD1 therapyJean-Marie Michot, Jacques Vargaftig, Charlotte Leduc, et al.
Oncotarget|April 14, 2017
Mechanisms of PD-1/PD-L1 expression and prognostic relevance in non-Hodgkin lymphoma: a summary of immunohistochemical studiesPauline Gravelle, Barbara Burroni, Sarah Péricart, et al.
Open Forum Infectious Diseases|January 17, 2022
<i>Listeria</i>-Associated Lymphadenitis: A Series of 11 Consecutive Cases and Review of the LiteratureMathieu Blot, Olivier Disson, Alexandre Leclercq, et al.
Haematologica|December 22, 2018
T-cell large granular lymphocyte leukemia transfomation into aggressive T-cell lymphoma: a report of two cases with molecular characterizationMaya Belhadj, Dalila Mansour, Sophie Kaltenbach, et al.
Blood Cells, Molecules & Diseases|December 4, 2019
Mastocytosis onset in a patient with treated hairy cell leukemia: Just a coincidence?Alice Boilève, Adrien Contejean, Sylvain Barreau, et al.
Rheumatology (Oxford, England)|December 23, 2021
Features of non-Hodgkin's lymphoma diagnosed in minor salivary gland biopsies from primary Sjögren's syndrome patientsSimon Parreau, Gaétane Nocturne, Xavier Mariette, et al.
Anti-Cancer Drugs|June 19, 2021
Successful nelarabine and venetoclax treatment of a relapsed/refractory mediastinal myeloid sarcoma with clonal TCR rearrangementAdrien Contejean, Patricia Palmic, Olivier Kosmider, et al.
European Journal of Cancer (Oxford, England : 1990)|October 16, 2024
The tumor immune microenvironment of SCLC is not associated with its molecular subtypesYoan Velut, Basilia Arqué, Marie Wislez, et al.
European Journal of Haematology|November 2, 2023
Extreme thrombocytosis with an aggressive evolution harboring a novel variant of calreticulin (CALR) in exon 3Sarah Bonnet, Serge Carillo, Baptiste Legrand, et al.
Pageof 6